(Nasdaq: MYNZ) Profile
OUR NEW PROFILE IS: (NASDAQ: MYNZ) __________ MAINZ BIOMED (NASDAQ: MYNZ) AIMS TO BECOME A LEADER IN THE MULTI-BILLION-DOLLAR COLORECTAL CANCER DIAGNOSTICS MARKET CE-IVD CLEARED FLAGSHIP PRODUCT COLOALERT IS THE FIRST DNA-BASED SCREENING TEST FOR COLORECTAL CANCER IN EUROPE MYNZ IS ALSO DEVELOPING PROPRIETARY GENETIC TESTING METHODS FOR PANCREATIC CANCER IN ADDITION TO COLOALERT, ALREADY […]
BRAND NEW PROFILE: (NASDAQ: IKT)
OUR NEW PROFILE IS: (NASDAQ: IKT) ______ VIEW THE INVESTOR PRESENTATION HERE Hello Everyone, We have another profile that is trading under a buck right now that sits on the Nasdaq that we want you to research. You know we loves these ones that are sitting under a dollar because of the massive swing potential. […]
(Nasdaq: CMND) Profile
OUR NEW PROFILE IS: (NASDAQ: CMND) __________ CMND TRADES IN CANADA (CSE: CMND) AS WELL AS GERMANY (FWB: CWY) READ THE INVESTOR PRESENTATION HERE _______________________ Hello Everyone, We have another exciting profile for you for for today’s session. This one operates in a unique, niche sector with a bright future ahead of it. With […]
Nasdaq: NMTC Profile
OUR NEW PROFILE IS: (NASDAQ: NMTC) Strategic partnership with Zimmer Biomet (NYSE:ZBH, ~$27B mkt cap) to exclusively commercialize and distribute EVO® diagnostic electrodes; accelerated payment of $3.5 million received in August 2022 Neurone® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use ****Breaking News This Morning***** NeuroOne® Awarded […]
BCAN Nasdaq Profile
OUR NEW PROFILE IS: (NASDAQ: BCAN) YAHOO FINANCE HAS THE ENTIRE FLOAT UNDER 1.2MILL!! THE EZ-G DEVICE REPRESENTED A $28 MILLION TRANSACTION BCAN IS AN EARLY PLAYER IN THE AI-POWERED ADULT TOY MARKET INSIDERS OWN OVER 64% OF THIS ONE!! _____________________ Pull up BCAN immediately. In the adult toy industry, AI and wearable sex toys have […]
NASDAQ: PBTS IS OUR NEW PROFILE!
OUR NEW PROFILE IS: (NASDAQ: PBTS) _________________ PBTS HAS OVER 300 EMPLOYEES MORE THAN 1600 COMPANIES TRUST US TO HELP THEM STREAMLINE THEIR OPERATIONS, IMPROVE INTER-DEPARTMENTAL EFFICIENCY, AND REDUCE OPERATIONAL OVERHEAD POWERBRIDGE TECHNOLOGIES UNVEILS PLANS TO LEVERAGE CHATGPT TECHNOLOGY FOR EARLY CHILDHOOD EDUCATION ____________ Hello Everyone, We have a new Nasdaq profile that we […]
NYSE: ATNM Profile
OUR NEW PROFILE IS: (NYSE: ATNM) _______________________ H.C. WAINWRIGHT & CO. PLACES $53.00 TARGET ON THIS $14 CLINICAL-STAGE BIOPHARMA STOCK INDICATING MASSIVE POTENTIAL UPSIDE ACTINIUM-225 BASED ALPHA THERAPIES HAVE TREATED APPROXIMATELY 150 PATIENTS TREATED ACROSS SIX PHASE 1 AND PHASE 2 CLINICAL TRIALS ACTINIUM ANNOUNCES POSITIVE FULL DATA RESULTS FROM THE PIVOTAL PHASE 3 SIERRA […]
(NASDAQ: HILS) Profile
OUR NEW PROFILE IS: (NASDAQ: HILS) _________________ THIS HAS A FLOAT UNDER 4M & A MARKET CAP UNDER 8M ! ! ! HILS IS ON THE MOVE CLOSING GREEN 8 OUT OF THE LAST 10 RECENT COLLABORATION ALLOWS HILLSTREAM TO ENTER THE RAPIDLY GROWING IMMUNO-ONCOLOGY THERAPEUTICS MARKET ___________________ https://platform.twitter.com/embed/Tweet.html?dnt=false&embedId=twitter-widget-0&features=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&frame=false&hideCard=false&hideThread=false&id=1620432672853200896&lang=en&origin=https%3A%2F%2Finsiderfinancial.com%2Fhils1%2F&sessionId=14fdb8539a8bdac5430a90f5a062199d64ed73c9&theme=light&widgetsVersion=aaf4084522e3a%3A1674595607486&width=550px […]
CSSI PROFILE
OUR NEW PROFILE IS: (OTC: CSSI) _______________ CSSI COMPLETES ACQUISITION OF FLORIDA BASED, PRIME DENTAL LAB, LLC COSTAS REPORTS 2022 3RD QUARTER REVENUE AND EXIT FROM SHELL STATUS THE ACQUISITION OF PRIME DENTAL DELIVERS MORE THAN TEN YEARS OF EXPERIENCE AND 2021 UNAUDITED GROSS REVENUE IN EXCESS OF $600,000. ______________________________ Hello […]
CTXR PROFILE
OUR NEW PROFILE IS: NASDAQ: CTXR “MINO-WRAP” COULD REVOLUTIONIZE $400 MILLION POST-MASTECTOMY INFECTION PREVENTION MARKET $41.7 MILLION IN CASH AND CASH EQUIVALENTS AS OF SEPTEMBER 30, 2022 MINO-LOK® PHASE 3 TRIAL CLOSER TO COMPLETION WITH 169 PATIENTS RECRUITED, 72 FAILURE EVENTS AND 17 PATIENTS IN ACTIVE TREATMENT OR PENDING DATA REVIEW DOWNLOAD THE INVESTOR […]